Core Faculty member William Shih & his team at the Wyss & @danafarber.bsky.social have recently published a computational framework that standardizes the design & fabrication of crisscross megastructures to make nanotechnology more broadly accessible in @natcomms.nature.com. #NanotechnologyDay
Last weekend, Wyss researchers co-hosted a booth with our friends at ECHO at the Cambridge Science Carnival, a family-friendly science event. They taught visitors about Organ Chips, microfluidic devices lined with living human cells that mimic human organs.
Dr. Ernest Aguinam is using Lymph Node Organ Chips to study the immune system and ultimately develop medical countermeasures for radiation injury and chronic #LymeDisease.
Learn more about Dr. Aguinam and his work at the @wyssinstitute.bsky.social: https://bit.ly/4dHNpgy
From developing plastics that actually break down to adhesive gels for surgery, the Wyss Institute’s materials scientists are working to save the future. In this video, four Wyss researchers speak with host Ashley Christine to discuss how they’re using materials science to make a positive impact.
Wyss researchers are developing MenoSense, an at-home system that combines a minimally invasive hydrogel microneedle patch, a compact reader to measure three key hormones, and a smartphone app that pairs hormone trends with self-reported symptoms. #WorldMenopauseMonth
A collaborative Wyss team made up of members of four different faculty labs, with support from the @arpa-h.bsky.social MOCS program, is working to develop a molecular oxygen-sensing technology for fetal health monitoring during labor.
Wyss startup Prapela is leveraging stochastic resonance technology developed at the Institute to produce an inexpensive mattress pad that delivers barely-detectable random vibrations to help soothe infants and normalize their breathing to address neonatal opioid withdrawal syndrome and infant apnea.
CircaVent is a high-throughput drug screening platform that combines predictive algorithms, preclinical models, and human brain organoids to efficiently identify and test drugs that could treat the underlying causes of bipolar disorder.
If Samir Mitragotri had to choose a different career, he might be a painter, turning his hobby into a job. Instead, he’s a Core Faculty member at the Wyss and a Professor at @harvardseas.bsky.social.
Learn more about him in this 20-ish Questions video: bit.ly/Mitragotri-2...
Research from Natalie Artzi’s group at the Wyss and @massgeneralbrigham.bsky.social developed a cancer vaccine that self-assembles in the body and forces tumors to become more visible to the immune system.
Last week, we co-hosted a screening of “The New Gold Standard” with Wyss startup @emulatebio.bsky.social. The film explores the emergence of human-based research technologies, such as Organ Chips, & how using them can fundamentally change and improve how drugs are discovered, tested, and approved.
Ana Raquel Santa Maria, a scientist in the Wyss Brain Targeting Program, is among 11 researchers receiving funding from the EQT Foundation for a project aimed at finding new ways to overcome the challenge of delivering therapeutics to the brain and central nervous system.
bit.ly/4yY3FSI
How is developing drugs like writing a song? Ernest Aguinam starts with a hypothesis or a new lyric, tests variables, & aims for impact. At the Wyss, Ernest uses Lymph Node Organ Chips to study the immune system and develop new therapies. Learn more about Ernest & his work in this month’s #HOWyss.
Seeing her ex struggle with bipolar disorder motivates Maria C.B. Gonçalves' work to better understand & identify potential treatments for mental illnesses as part of the CircaVent Team. It inspires her to #ReimagineTheWorld as a place where people feel supported and safe to seek help.
The Wyss Validation Projects reflect the breadth and depth of work at the Institute. These 23 teams receive dedicated funding, technical resources, business development support, and market research to move their technologies beyond discovery and further de-risk them, with the goal of translation.
Wyss researchers have developed TIBs, a biomaterial-based therapy that delivers regulatory T cells to injury sites and maintains their pro-regenerative potential there over extended periods of time. This could facilitate tissue regeneration in musculoskeletal diseases & following injuries.
Researchers at the Wyss, @harvardmed.bsky.social, and the @stanforddoerr.bsky.social worked together to develop a new way to potentially cool the planet by accelerating rock weathering, the natural breakdown and dissolving of rocks and minerals.
A new discovery about transfer RNAs led to a tool called AGENTEX that allows researchers to produce synthetic proteins faster, more safely, and at a larger scale than ever before. This work promises to expand the development of novel protein-based medicines and other materials.
It's #PostdocAppreciationWeek! To celebrate, we held an event for our postdocs where they enjoyed eating food, playing pool, bowling, and chatting with colleagues.
Recognize and thank the postdocs in your life for their valuable mentorship, innovative ideas, and skillful leadership!
Labs generate nearly 12 times as much waste per square foot as office spaces. The Wyss lab recycling program is taking steps to change that. In honor of #PollutionPreventionWeek, learn from Lab Safety Officer Hannah Morrissey about the program, what makes it unique, & what's coming next.
